Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia. 2022

Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
Department of Nephrology, Peupliers Private Hospital, Paris, France.

UI MeSH Term Description Entries

Related Publications

Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
January 2013, Renal failure,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
December 1983, Cancer,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
April 2023, Expert opinion on pharmacotherapy,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
June 2021, Blood,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
December 2022, Leukemia & lymphoma,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
February 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
January 2016, The New England journal of medicine,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
January 2022, Clinical advances in hematology & oncology : H&O,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
January 2000, American journal of nephrology,
Hassan Izzedine, and Isabelle Brocheriou, and Alexis Mathian, and David Ghez, and Zahir Amoura
January 2021, Therapeutic advances in hematology,
Copied contents to your clipboard!